Last reviewed · How we verify
Prevention of Ventricular Fibrillation
Approved treatments
- Bretylium Tosylate · Pfizer
- Cordarone · Pfizer
Amiodarone, a class III antiarrhythmic, blocks sodium, potassium, and calcium channels, prolongs cardiac action potentials, and has vasodilatory effects.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Ventricular Fibrillation patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Ventricular Fibrillation treatment landscape brief
- Prevention of Ventricular Fibrillation treatment updates RSS
Frequently asked questions about Prevention of Ventricular Fibrillation
What drugs treat Prevention of Ventricular Fibrillation?
Tracked treatments include Bretylium Tosylate, Cordarone.
What is the treatment for Prevention of Ventricular Fibrillation?
Standard treatment for Prevention of Ventricular Fibrillation includes Bretylium Tosylate, Cordarone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of Ventricular Fibrillation patent cliff · Prevention of Ventricular Fibrillation CI report
- Treatment: Bretylium Tosylate · Pfizer
- Treatment: Cordarone · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing